2018 CABA Annual Conference

May 19, 2018

Welcome to the Boston Bioforum 2018-Chinese American BioMedical Association (CABA) Annual Conference. The theme of this year's annual conference is: Catching the Wave: Trends and Disruptive Technologies in Biomedical R&D. There are 4 focusing areas this year: cell and gene therapy, trends in biomedical research, investment across borders, and career path in the US and China. 

Location: Boston Marriott Newton, 2345 Commonwealth Avenue , NEWTON , MA , 02466

 Time: 08:00 a.m. - 9:00 p.m., Saturday, May 19th, 2018 

Tentative Agenda

8:00 am - 9:00 am             REGISTRATION / VENDOR SHOW

9:00 am - 9:10 am             OPENING REMARKS

Bo Ying, PhD, Conference Chair

9:10 am - 9:30 am             INTRODUCTION OF CABA

Kevin Fang, PhD, President, CABA

9:30 am - 12:00 pm          SESSION I - CELL & GENE THERAPY

Cellframe, a Revolutionary Organ Regeneration Platform

William Fodor, PhD, Chief Scientific Officer, Biostage

Title TBD

Felix Hsu, SVP, Head of WuXi Advanced Therapies

Transforming Standard of Care via Single Dose Gene Therapy

Geoff Mckay, CEO, Avrobio

Title TBD

Stefan Willdt, SVP, Takeda

Title TBD

Birgit Schultes, PhD, VP of Immunology, Intellia Therapeutics Inc.

12:00 pm - 1:00 pm          LUNCH AND CAREER PATH ROUND TABLE

1:00 pm - 2:30 pm            SESSION II – TRENDS IN BIOMEDICAL RESEARCH

Creating an Effective, AI-driven Company for Drug Development on the Cloud

Yide Alan Jiang, PhD, Chief Strategic Officer, Xtalpi Inc.

CRISPR Screens and Big Data Mining for Precision Cancer Medicine

Xiaole Shirley Liu, PhD, Professor of Statistics, Biostatistics, and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health

Title TBD

Tong-Tong Xue, PhD, CEO of Kelun Bo-Tai Biological Company and Vice President of Kelun Pharmaceutical Research Institute

2:30 pm - 3:00 pm            COFFEE BREAK AND VENDOR SHOW

3:00 pm - 5:30 pm            SESSION III - INVESTMENT ACROSS BORDERS

Venture Creation of Cross-Border Life Sciences Companies

Cheryl Cui, PhD, Partner, Nest.Bio Ventures, Venture Partner, Venture Health

Sailing Westward by China Biopharm Firms

Sean Fu, PhD, Vice President of Luye Global R&D, President of Luye Boston R&D   

Trends in Cross-Border Transactions

Debra Yu, MD, Managing Director, Head of Cross-Border Healthcare Investment Banking, China Renaissance

From Entrepreneur to Investor: a Novel Way to Experience Inorganic Business

Johnson Zhang, MBA, Vice President & General Manager, Perkin Elmer APAC

6:00 pm - 9:00 pm            SESSION V - DINNER RECEPTION

6:00 pm - 6:45 pm            KEYNOTE

6:45 pm - 7:30 pm            CABA ANNOUNCEMENT

7:30 pm - 9:00 pm            SOCIAL AND NETWORKING

Register Here